Nicotinamide Adenine Dinucleotide Market Report 2026
Global Outlook – By Product Type (Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations), By Grade (Food Grade, Pharmaceutical Grade, Other Grades), By Distribution Channel (Online and E-commerce, Offline Channels), By Application (Dietary Supplements and Wellness, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology), By End User (Individual Consumers, Healthcare Providers, Pharmaceutical Companies) – Market Size, Trends, Strategies, and Forecast to 2030
Nicotinamide Adenine Dinucleotide Market Overview
• Nicotinamide Adenine Dinucleotide market size has reached to $5.59 billion in 2025 • Expected to grow to $11.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: Rising Prevalence Of Age-Related And Metabolic Disorders Driving The Growth Of The Market Due To Increasing Need For Cellular Energy And Metabolic Support • Market Trend: Supporting Cellular Health And Aging With Precision Blends, Clinically Studied NAD+ Precursors, And Targeted Wellness Benefits • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Nicotinamide Adenine Dinucleotide Market?
Nicotinamide adenine dinucleotide (NAD⁺) is a vital coenzyme found in all living cells that plays a key role in cellular metabolism. It functions primarily as an electron carrier in redox reactions, helping convert nutrients into energy by transferring electrons in processes such as glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also involved in DNA repair, gene expression regulation, and cell signaling. The main product types of nicotinamide adenine dinucleotide (NAD) include oral nicotinamide adenine dinucleotide supplements, nicotinamide adenine dinucleotide and NADH direct-ingredient capsules, nicotinamide adenine dinucleotide injection and infusion products, specialized anti-aging and metabolic formulations, nicotinamide adenine dinucleotide precursors, and topical and cosmetic nicotinamide adenine dinucleotide formulations. Oral nicotinamide adenine dinucleotide supplements refer to orally administered formulations that provide nicotinamide adenine dinucleotide or its precursors to support cellular energy metabolism, healthy aging, and overall wellness. The various grades, including food grade, pharmaceutical grade, and others. The distribution channels online and e-commerce and offline channels. The application such as dietary supplements and wellness, pharmaceuticals and therapeutics, cosmetics and dermatology, clinical IV therapy, regenerative medicine, and research and biotechnology and the key end users including individual consumers, healthcare providers, and pharmaceutical companies.
What Is The Nicotinamide Adenine Dinucleotide Market Size and Share 2026?
The nicotinamide adenine dinucleotide market size has grown rapidly in recent years. It will grow from $5.59 billion in 2025 to $6.48 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing demand for anti-aging supplements, growing research on cellular metabolism, rising awareness of preventive healthcare, expansion of nutraceutical distribution channels, increasing adoption of wellness and biohacking products.What Is The Nicotinamide Adenine Dinucleotide Market Growth Forecast?
The nicotinamide adenine dinucleotide market size is expected to see rapid growth in the next few years. It will grow to $11.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growing consumer spending on longevity and vitality solutions, increasing adoption of nad precursors in mainstream supplements, rising expansion of IV therapy and regenerative clinics, increasing pharmaceutical interest in nad for chronic disease management, expanding penetration of online personalized supplement programs. Major trends in the forecast period include technology advancements in sustained-release and liposomal delivery formats, innovations in multi-ingredient longevity formulations, developments in nad-based dermatology and skincare actives, research and developments in therapeutic-grade nad for neurological and metabolic disorders, advancements in biomarker-based personalized supplementation platforms.
Global Nicotinamide Adenine Dinucleotide Market Segmentation
1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations 2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades 3) By Distribution Channel: Online and E-commerce, Offline Channels 4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology 5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies Subsegments: 1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules 2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules 3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends 4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas 5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends 5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation GelsWhat Is The Driver Of The Nicotinamide Adenine Dinucleotide Market?
The rising prevalence of age-related and metabolic disorders is expected to propel the growth of the nicotinamide adenine dinucleotide market going forward. Age-related and metabolic disorders refer to health conditions such as diabetes, obesity, cardiovascular diseases, and neurodegenerative disorders that are associated with aging, impaired metabolism, and cellular dysfunction. The prevalence of age-related and metabolic disorders is rising as as populations grow older while unhealthy lifestyle patterns such as sedentary behavior excessive calorie intake and rising obesity rates become more widespread. Nicotinamide adenine dinucleotide supports the management of age-related and metabolic disorders by playing a critical role in cellular energy metabolism, mitochondrial function, and DNA repair processes, which are essential for maintaining metabolic health and slowing age-associated cellular decline. For instance, in February 2025, according to the International Diabetes Federation, a Belgium-based non profit organization representing diabetes associations worldwide, the number of people aged above 65 years with diabetes is projected to reach 195.2 million accounting for 19.6% in 2030 and 276.2 million in 2045, highlighting a significant rise in the diabetes burden in aging societies over the next 25 years with major public health and economic implications. Therefore, the rising prevalence of age-related and metabolic disorders is driving the growth of the nicotinamide adenine dinucleotide industry.Key Players In The Global Nicotinamide Adenine Dinucleotide Market
Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Nicotinamide Adenine Dinucleotide Market Trends and Insights
Major companies operating in the nicotinamide adenine dinucleotide market are focusing on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to support anti-aging and improve skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements refer to dietary or topical products formulated to increase nicotinamide adenine dinucleotide (NAD+) levels in skin cells, supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For instance, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, the first NAD+ skincare supplement available in the United States, featuring a precision blend of clinically studied ingredients, including its patented nicotinamide riboside (Niagen). This formulation is designed to support cellular energy production, skin health, and overall wellness by increasing NAD+ availability, which naturally declines with age.What Are Latest Mergers And Acquisitions In The Nicotinamide Adenine Dinucleotide Market?
In October 2023, L Catterton Management Company LLC, a US-based consumer-focused investment firm, acquired Thorne HealthTech Inc. for an undisclosed amount. With this acquisition, L Catterton expanded its presence in personalized wellness and longevity-oriented nutrition markets, leveraging Thorne’s established product portfolio, research and development capabilities, and direct-to-consumer reach. Thorne HealthTech Inc. is a US-based nutritional supplement company focusing on nicotinamide adenine dinucleotide (NAD)-related health products.
Regional Insights
North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Nicotinamide Adenine Dinucleotide Market?
The nicotinamide adenine dinucleotide market consists of sales of NAD⁺ supplements, NADH formulations, nicotinamide riboside (NR) products, nicotinamide mononucleotide (NMN) products, and related nutraceuticals and functional foods. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Nicotinamide Adenine Dinucleotide Market Report 2026?
The nicotinamide adenine dinucleotide market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nicotinamide adenine dinucleotide industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Nicotinamide Adenine Dinucleotide Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $6.48 billion |
| Revenue Forecast In 2030 | $11.65 billion |
| Growth Rate | CAGR of 16.1% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Grade, Distribution Channel, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |